Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot trial of pegfilgrastim in elderly AML patients without chemotherapy indications
2006-006541-14Phase 2Terminated
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegfilgrastim in acute myeloid leukemia (AML), sponsored by ASST Spedali Civili di Brescia. Primary endpoints: Hematologic response in peripheral blood and Overall survival. Started Aug 2007; status: terminated.
02
Drugs
pegfilgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2006-006541-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006541-14.